Medicine and Dentistry
Acute Pulmonary Embolism
38%
Biopsy Technique
68%
Bone Metastasis
33%
Bone Scintigraphy
32%
Cardiovascular System
26%
Castration Resistant Prostate Cancer
45%
Chronic Obstructive Pulmonary Disease
22%
Computer Assisted Tomography
74%
Copper 64
47%
Cost-Effectiveness Analysis
27%
Diagnosis
54%
Diffusing Capacity
24%
Diseases
26%
Emphysema
23%
Fluorodeoxyglucose F 18
24%
Forced Expiratory Volume
28%
Health Care Cost
25%
Indium 111
31%
Iodine 123
25%
Limb Perfusion
33%
Low Drug Dose
78%
Lung
69%
Lung Cancer
93%
Lung Cancer Screening
64%
Lung Function
47%
Lung Transplantation
36%
Lung Ventilation
45%
Lymph Node Metastasis
25%
Metastatic Carcinoma
23%
Mouth Squamous Cell Carcinoma
37%
Neoplasm
52%
Neuroendocrine Tumor
91%
Non Small Cell Lung Cancer
39%
Octreotide
29%
Oral Cancer
56%
Polyethylene Terephthalate
64%
positron emission tomographic scan
83%
Positron Emission Tomography-Computed Tomography
48%
Prevalence
32%
Prospective Study
29%
Pulmonary Embolism
98%
Radioactive Tracer
33%
Scintigraphy
73%
Sentinel Lymph Node
26%
Sentinel Node
47%
Single Photon Emission Computed Tomography-Computed Tomography
75%
Single-Photon Emission Computed Tomography
70%
Somatostatin Receptor
37%
Spirometry
39%
Technetium-99
33%
Keyphrases
64Cu-DOTATATE
45%
Acute Pulmonary Embolism
38%
Bone Metastasis
22%
Brain Natriuretic Peptide
22%
Chronic Obstructive Pulmonary Disease
22%
Computed Tomography
31%
Confidence Interval
23%
Diagnostic Accuracy
24%
Diffusing Capacity
26%
Football Training
22%
Forced Expiratory Volume in 1 Second (FEV1)
41%
Gene Expression
22%
Head-to-head Comparison
56%
Hyperthermic Isolated Limb Perfusion
33%
Low-dose Computed Tomography
23%
Low-dose CT
39%
Lung
21%
Lung Cancer
24%
Lung Cancer Screening
45%
Lung Cancer Staging
37%
Lung Function
56%
Lymph Node Metastasis
25%
Metabolic Syndrome
22%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
24%
Middle-aged Women
22%
Mucociliary Clearance
22%
Neuroendocrine Tumor
79%
Non-small Cell Lung Cancer (NSCLC)
27%
Oral Cancer
22%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
32%
Perfusion
33%
Positron Emission Tomography
22%
Positron Emission Tomography-computed Tomography (PET-CT)
52%
Positron Emission tomography-CT
33%
Preoperative Staging
22%
Primary Graft Dysfunction
22%
Pulmonary Embolism
94%
Pulmonary Function
33%
Radium-223
33%
Randomized Controlled Trial
22%
Right Ventricular Function
25%
Scintigraphy
34%
Sentinel Lymph Node
26%
Sentinel Lymph Node Biopsy
33%
Single-photon Emission Computed Tomography (SPECT)
100%
Soccer Training
22%
SPECT-CT
30%
Spirometry
50%
Testicular Cancer Survivors
22%
Ventilation-perfusion Ratio
25%
